Cargando…
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
BACKGROUND: Managing severe asthma during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is challenging, particularly due to safety concerns regarding the use of systemic corticosteroids and biologics. OBJECTIVES: We sought to determine the association between biologics or...
Autores principales: | Adir, Yochai, Humbert, Marc, Saliba, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205279/ https://www.ncbi.nlm.nih.gov/pubmed/34144110 http://dx.doi.org/10.1016/j.jaci.2021.06.006 |
Ejemplares similares
-
Asthma and COVID-19: an update
por: Adir, Yochai, et al.
Publicado: (2021) -
Association between sex and SARS-CoV-2 infection and hospitalisation as a result of COVID-19
por: Adir, Yochai, et al.
Publicado: (2021) -
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022) -
Pediatric Asthma & Coronavirus (COVID-19)-Clinical Presentation in an Asthmatic Child—Case Report
por: Barsoum, Zakaria
Publicado: (2020) -
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective
por: Skevaki, Chrysanthi, et al.
Publicado: (2023)